123 related articles for article (PubMed ID: 18810795)
1. Contaminated heparin.
Kakkar AK; Bonnefoi M
N Engl J Med; 2008 Sep; 359(12):1292-3; author reply 1293. PubMed ID: 18810795
[No Abstract] [Full Text] [Related]
2. [Artificial polysaccharide in contaminated heparin. Acute hypersensitivity reactions explained--but how could it happen?].
Lindahl U
Lakartidningen; 2008 Sep 24-30; 105(39):2660-1. PubMed ID: 18846871
[No Abstract] [Full Text] [Related]
3. Contaminated heparin.
Greinacher A; Warkentin TE
N Engl J Med; 2008 Sep; 359(12):1291-2; author reply 1293. PubMed ID: 18799565
[No Abstract] [Full Text] [Related]
4. Contaminated heparin associated with adverse clinical events and activation of the contact system.
Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R
N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646
[TBL] [Abstract][Full Text] [Related]
5. Heparin comes clean.
Schwartz LB
N Engl J Med; 2008 Jun; 358(23):2505-9. PubMed ID: 18525048
[No Abstract] [Full Text] [Related]
6. Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat.
Corbier A; Le Berre N; Rampe D; Meng H; Lorenz M; Vicat P; Potdevin S; Doubovetzky M
Toxicol Sci; 2011 Jun; 121(2):417-27. PubMed ID: 21436127
[TBL] [Abstract][Full Text] [Related]
7. The tainted heparin story: an update.
Guerrini M; Shriver Z; Bisio A; Naggi A; Casu B; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):907-11. PubMed ID: 19888527
[TBL] [Abstract][Full Text] [Related]
8. Contaminants in heparins continue to be unfolded.
Fareed J; Ahluwalia M; Wahi R; Ramaccioti E; Hoppensteadt D; Bick RL
Int Angiol; 2008 Dec; 27(6):457-61. PubMed ID: 19078906
[No Abstract] [Full Text] [Related]
9. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
[TBL] [Abstract][Full Text] [Related]
10. Contaminants in heparins: are all facts known?
Fareed J; Hoppensteadt DA; Ramacciotti E; Hull RD
Clin Appl Thromb Hemost; 2010 Jun; 16(3):242-3. PubMed ID: 20547552
[No Abstract] [Full Text] [Related]
11. Contaminated heparin-affected patient plasmas are associated with activated contact systems.
Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Beck AM; Shih FF; Lijuan Zhang
Clin Appl Thromb Hemost; 2010 Jun; 16(3):261-5. PubMed ID: 20547554
[No Abstract] [Full Text] [Related]
12. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.
Bairstow S; McKee J; Nordhaus M; Johnson R
Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093
[TBL] [Abstract][Full Text] [Related]
13. [Anaphylactoid reactions associated with contaminated heparin from China].
Montpas N; Désormeaux A; Keire D; Adam A
Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
[TBL] [Abstract][Full Text] [Related]
14. Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.
Ramacciotti E; Clark M; Sadeghi N; Hoppensteadt D; Thethi I; Gomes M; Fareed J
Clin Appl Thromb Hemost; 2011 Apr; 17(2):126-35. PubMed ID: 21288929
[TBL] [Abstract][Full Text] [Related]
15. From crisis to opportunity: a perspective on the heparin crisis.
Sasisekharan R; Shriver Z
Thromb Haemost; 2009 Nov; 102(5):854-8. PubMed ID: 19888519
[No Abstract] [Full Text] [Related]
16. Contaminants in heparin.
Hull R; Walenga J
Clin Appl Thromb Hemost; 2011 Apr; 17(2):125. PubMed ID: 21406418
[No Abstract] [Full Text] [Related]
17. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes.
Warkentin TE; Greinacher A
Expert Opin Drug Saf; 2009 Mar; 8(2):129-44. PubMed ID: 19309242
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cytokine secretion from lymphocytes of patients with hypersensitivity reactions to contaminated heparins.
Martin M; Ott H; Merk HF; Sachs B
Br J Dermatol; 2011 Jan; 164(1):68-75. PubMed ID: 20854434
[TBL] [Abstract][Full Text] [Related]
19. Contaminated heparin preparations, severe adverse events and the contact system.
Ramacciotti E; Wahi R; Messmore HL
Clin Appl Thromb Hemost; 2008 Oct; 14(4):489-91. PubMed ID: 18815138
[No Abstract] [Full Text] [Related]
20. Prothrombin time for detection of contaminated heparins.
Alban S; Lühn S
N Engl J Med; 2008 Dec; 359(25):2732-4. PubMed ID: 19052118
[No Abstract] [Full Text] [Related]
[Next] [New Search]